Info

This news article was originally written in Spanish. It has been automatically translated for your convenience. Reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace a human translator. The original article in Spanish can be viewed at Un estudio internacional desvela cómo actúan los fármacos antitumorales a nivel molecular

An international study desvela how act the drugs antitumorales to molecular level

05/02/2013

5 February 2013

Imagen

An international study in which it has participated the Upper Council of Scientific Investigations (CSIC) has desvelado the molecular mechanism that employ the drugs antitumorales based in agents stabilisers of microtubules to avoid the division of the cells. The finding has been possible thanks to an isolated compound of a sponge of the Big Barrier of Australian Choral. The results of the work, published in Science, could help to design drugs more effective against those tumors with greater resistance to the current treatments of chemotherapy.

The agents stabilisers of microtubules constitute one of the main groups of drugs antitumorales that exist nowadays. This type of drugs applies in numerous pathologies tumorales feminine, as in the tumors of ovary and breast, as well as in the tumors of lung.

“This type of drugs antitumorales active the molecules of tubulin, the responsible protein of the separation of the chromosomes, and stabilises the microtubules that forms so that they can not divide the cells”, explains the researcher of the CSIC Fernando Díaz, of the Centre of Biological Investigations.

Zampanolida

The responsible researchers of the study have attained to determine the structure in high resolution of the complex activated of tubulin by means of a new compound antitumoral, Zampanolida, isolated of a sponge of the Big Barrier of Australian Choral.

“This structure to big resolution will allow to know in detail the determinantes structural that these compounds use to activate the tubulin in the cells tumorales. This will allow to improve the design of drugs, especially against those resistant tumors to the agents quimioterapéuticos into use at present”, adds Díaz.

In the study have participated the Institute Paul Scherrer of Villigen (Switzerland), the Institute of Pharmaceutical Sciences of the Federal Institute of Swiss Technology, the University of Wellington (New Zealand) and of the Centre of Biological Investigations of the CSIC.

Related Companies or Entities

Consejo Superior de Investigaciones Científicas

Suscríbase a nuestra Newsletter - Ver ejemplo

Password

Select all

Autorizo el envío de newsletters y avisos informativos personalizados de interempresas.net

I authorize the sending of communications from third parties via interempresas.net

He leído y acepto el Legal notice y la Data protection policy

Responsable: Interempresas Media, S.L.U. Purpose: Subscription to our newsletter(s). User account management. Sending emails related to the same or related to similar or associated interests.Retention: for the duration of the relationship with you, or as long as necessary to carry out the specified purposesTransfer: Data may be transferred to other group companies for internal management purposes.Rights: Access, rectification, opposition, deletion, portability, limitation of processing and automated decisions: contact our DPD. If you consider that the processing does not comply with the regulations in force, you may lodge a complaint with the AEPD.More information: Data protection policy

REVISTAS

TOP PRODUCTS

NEWSLETTERS

  • Newsletter Química

    04/07/2024

  • Newsletter Química

    27/06/2024

Highlighted links

Smagua - Feria de ZaragozaAWA Show2beSalón de gas renovable

Latest news

Featured companies

OPINIÓN

OTRAS SECCIONES

Services